MARKET

ITRM

ITRM

Iterum Therapeutics Plc
NASDAQ
0.3700
-0.0109
-2.86%
After Hours: 0.3800 +0.01 +2.70% 19:37 12/19 EST
OPEN
0.3777
PREV CLOSE
0.3809
HIGH
0.3919
LOW
0.3700
VOLUME
382.02K
TURNOVER
--
52 WEEK HIGH
2.100
52 WEEK LOW
0.3622
MARKET CAP
19.53M
P/E (TTM)
-0.4941
1D
5D
1M
3M
1Y
5Y
1D
Iterum Therapeutics provides business update
TipRanks · 3d ago
BRIEF-Iterum Therapeutics Provides Business Update
Reuters · 3d ago
Iterum Therapeutics Announces Japanese Patent Office Decision to Grant Patent Covering Sulopenem Combination, Expiring in 2041
Reuters · 3d ago
Weekly Report: what happened at ITRM last week (1208-1212)?
Weekly Report · 5d ago
Iterum Therapeutics Faces Nasdaq Listing Compliance Challenge
TipRanks · 12/12 22:34
Iterum Therapeutics Faces Nasdaq Delisting Risk Over Listing Rule Noncompliance
Reuters · 12/12 22:01
Weekly Report: what happened at ITRM last week (1201-1205)?
Weekly Report · 12/08 09:32
Buy Rating Affirmed for Iterum Therapeutics Amid Strategic Launch of ORLYNVAH and Strong Market Positioning
TipRanks · 12/08 08:05
More
About ITRM
Iterum Therapeutics plc is a clinical-stage pharmaceutical company. The Company develops differentiated anti-infectives. It offers ORLYNVAH (sulopenem in an oral tablet formulation) medicine, which is an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women. Sulopenem is a potent, thiopenem antibiotic delivered intravenously which is active against bacteria that belong to the group of organisms known as gram-negatives and cause urinary tract and intra-abdominal infections. The Company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Webull offers Iterum Therapeutics PLC stock information, including NASDAQ: ITRM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ITRM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ITRM stock methods without spending real money on the virtual paper trading platform.